Patent Opposition Strategy

EPO opposition is one of the most powerful and cost-effective tools for invalidating a granted European Patent, and it is widely used by companies seeking to prevent competitors from enforcing broad patents across Europe: EPO OPPOSITION — OVERVIEW: any third party (individuals; companies; patent attorneys on behalf of undisclosed clients) may oppose a granted European Patent; filing deadline: 9 months from the date of publication of the mention of the grant in the European Patent Bulletin (the European Patent Register); fee: €850 (EPO opposition fee); GROUNDS FOR OPPOSITION (Article 100 EPC): (a) lack of novelty (Article 54 EPC): the invention was known from the prior art; (b) lack of inventive step (Article 56 EPC): the invention would have been obvious to a person skilled in the art; (c) insufficient disclosure (Article 83 EPC): the application does not disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art; (d) added subject matter (Article 123(2) EPC): the claims or description contain subject matter extending beyond the content of the application as filed; (e) excluded subject matter (Article 53 EPC): the subject matter is not patentable (methods of treatment; computer programs as such; etc.); OPPOSITION PROCEEDINGS: OPPOSITION DIVISION: a panel of three technically trained examiners; different from the examining division that granted the patent; oral proceedings: almost always requested; provide opportunity to present arguments in person; critical for complex cases; PATENT OWNER RESPONSE: patent owner can amend claims to overcome the opposition; amendment must not extend beyond original disclosure; claims cannot be broadened; OUTCOME POSSIBILITIES: revocation (patent revoked in full; approximately 30% of oppositions); maintained as amended (claims narrowed; approximately 30%); maintained as granted (opposition rejected; approximately 40%); APPEAL: either party can appeal to the Technical Board of Appeal (TBA); appeal does not stay proceedings; EFFECT: an EPO opposition decision (revocation or amendment) automatically affects ALL European Patent bundle national validations; STRATEGIC USE: companies should monitor granted European Patents by competitors; file pre-opposition observation (free; anonymous) if want to submit art without becoming a party; file opposition if the patent is business-critical; budget €15,000-€50,000+ in attorney fees through first instance decision; TIMELINE: typically 2-4 years from filing opposition to final decision (including appeals can be 4-8 years).

Pre-issuance third party submissions are a highly underutilized patent challenge tool that allows any party to submit prior art into a pending patent application — before a patent grants — at essentially no cost and without becoming a party to the proceedings: WHAT IS A PRE-ISSUANCE SUBMISSION: under 37 C.F.R. § 1.290 (AIA-created procedure), any member of the public may submit prior art to a pending patent application; the submission must be made before: (1) the date of mailing of a notice of allowance; AND (2) the later of: 6 months from the date the application was first published, or the date of the first office action on the merits (whichever is later); WHO CAN FILE: anyone — competitor; industry association; academic institution; civil society organization; the filer does not need to identify themselves to the USPTO; WHAT CAN BE SUBMITTED: patents and published patent applications (US or foreign); journal articles; books; technical papers; standards documents; ANY prior art printed publication; limited to 10 references; must include a concise explanation (maximum one page per reference) of the relevance of each reference to at least one claim; IMPORTANT LIMITATIONS: filer gets no notice of examination actions; filer cannot participate in the examination; filer has no appeal rights; filer is NOT a party to the prosecution; NO ESTOPPEL: unlike IPR/PGR/PTAB proceedings, filing a pre-issuance submission does NOT create any estoppel against the filer; the filer retains full rights to challenge the patent after grant (IPR; PGR; district court invalidity); COST: USPTO fee: $180 for up to 3 references; additional fees for additional references; attorney preparation: $3,000-$10,000 typical; WHY THEY ARE EFFECTIVE: examiners face heavy workloads and limited search resources; well-presented prior art with clear explanation of relevance = examiner often relies on it; pre-issuance submissions have been shown to: (a) increase prosecution uncertainty (more office actions issued); (b) lead to claim narrowing; (c) lead to claim abandonment; (d) occasionally lead to complete patent denial; MONITORING COMPETITOR APPLICATIONS: use USPTO Patent Center or commercial monitoring services (Derwent; CPA Global; MaxVal) to track competitor applications as they publish (18 months after filing); when a competitor publishes a broad application that threatens your business, evaluate and file within the timing window.

A systematic patent challenge program goes beyond reactive defense (challenging patents when sued) to proactively monitoring and challenging competitor patents before they become enforcement problems: WHY PROACTIVE PATENT CHALLENGES MATTER: waiting until sued to challenge a patent is expensive and high-risk; a proactive challenge program identifies threatening patents early — when IPR or PGR are still available and before the patent holder has filed complaints that trigger estoppel risks; BUILDING A PATENT MONITORING PROGRAM: PATENT LANDSCAPE MAPPING: annually map the patent landscape in your technology area; identify: all granted patents; all pending applications; focus areas: competitor portfolios (track specific assignees); standard essential patents in your industry; key technology areas (search by CPC classification); TOOLS: Google Patents (free; customizable alerts); Derwent Innovation (comprehensive; $$$); Questel Orbit; MaxVal; PatSnap; set automated watch notifications for: new publications by competitor assignees; allowed applications in critical technology classes; TIERED REVIEW PROCESS: TIER 1 (IMMEDIATE REVIEW): any patent or application that directly claims your current products or core technology; any patent naming key competitor technologies; any SEP in a standard you implement; TIER 2 (PERIODIC REVIEW): adjacent technology areas; continuation filings by competitors in tracked families; TIER 3 (ANNUAL SURVEY): broad technology landscape; expired or dormant portfolios; CHALLENGE TIMELINE DECISION TREE: APPLICATION PENDING (before grant): → pre-issuance third party submission (cheapest; no estoppel; anonymous); → patent prosecution highway (if you have related patents; affects competitor's prosecution); WITHIN 9 MONTHS OF GRANT: → post-grant review (PGR) — most powerful challenge venue; all invalidity grounds available; → EPO opposition if European patent; AT ANY TIME: → ex parte reexamination (no timing bar; limited participation); → district court invalidity defense (when sued; clear and convincing standard); MORE THAN 1 YEAR AFTER SERVICE OF COMPLAINT: → only ex parte reexamination remains as USPTO option; district court invalidity defense; BUDGET ALLOCATION: pre-issuance submissions: $3,000-$10,000 each; IPR petition: $200,000-$400,000 through trial; PGR petition: similar to IPR; ex parte reexamination: $15,000-$30,000 initial + ongoing; BUILD INTERNAL KNOWLEDGE DATABASE: maintain records of: patents monitored; challenges filed; outcomes; prior art found (even if not filed); this database informs future prosecution of your own applications and invalidity defenses if sued.

Each major patent system has its own mechanism for third-party challenges to granted patents, and a comprehensive patent challenge strategy requires understanding the timing and procedure at each relevant national office: JAPAN PATENT OFFICE (JPO) OPPOSITION (Opposition Trial): WHEN: within 6 months from the date of publication of the patent gazette (patent registration); GROUNDS: novelty; inventive step; industrial applicability; insufficient disclosure; lack of unity; WHO CAN FILE: any person (even anonymous); PROCEDURE: JPO Examination Division reviews; can request oral hearing; patent owner can amend claims during proceedings; TIMELINE: 9-15 months typical; OUTCOME: maintained; amended; revoked; APPEAL: appeal to JPO Board of Appeal → Tokyo IP High Court; TRIAL FOR INVALIDATION (Muko Shinpan): available at any time (no deadline); any interested party; broader grounds including correction of inventorship; KOREA PATENT COURT SYSTEM (KIPO): POST-GRANT OPPOSITION (Relocation System): abolished in 2017; replaced by full invalidation trial system; INVALIDATION TRIAL (Musyo Simpal): can be filed any time during patent term; any person with an interest; grounds: prior art (novelty; inventive step); insufficient disclosure; not patentable subject matter; PROCEDURE: KIPO Patent Tribunal (IPTAB) adjudicates; oral hearings; 9-18 months; APPEAL: Patent Court → Supreme Court; OBSERVATIONS: any third party can submit observations during examination (similar to EPO third party observations; no party status); CHINA PATENT REEXAMINATION AND INVALIDATION: INVALIDATION (Wuxiao Xuanqing): CNIPA Reexamination and Invalidation Division; any member of the public may file invalidation request at any time during patent term; grounds: prior art (novelty; inventive step); insufficient disclosure; non-patentable subject matter; lack of unity; PROCEDURE: administrative proceeding at CNIPA; written submissions; oral hearings at CNIPA; TIMELINE: 6-24 months depending on complexity; OUTCOME: declared invalid (all claims or partial); or maintained; EFFECT: invalid declaration is administrative; patent is cancelled from date of grant (retroactive); Chinese invalidity proceedings are frequently filed by accused infringers simultaneously with infringement defense; APPEAL: appeal to Beijing IP Court → Beijing High Court → Supreme People's Court; parallel invalidation + infringement proceedings common in China; STRATEGIC COORDINATION: file EPO opposition (9 months from grant) simultaneously with early monitoring; file KIPO invalidation for Korea-specific patents; Chinese invalidation as defensive tool when sued in China; JPO invalidation for Japan-specific business-critical patents; pre-issuance USPTO submissions for pending US applications; coordinate timing so US IPR window (1 year from complaint) is preserved if district court litigation begins.